Designed and created by Guideline Central in participation with the International Organization for the Study of Inflammatory Bowel Diseases
Dietary Guidance for Patients with Inflammatory Bowel Disease
Patient Guideline Summary
Publication Date: February 14, 2020
Last Updated: November 28, 2023
This patient summary means to discuss key recommendations from the IOIBD, the International Organization for the Study of Inflammatory Bowel Disease for Dietary Guidance for Inflammatory Bowel Diseases.
- Crohn’s disease and ulcerative colitis are serious inflammatory diseases of the bowels.
- There is not a lot of information available on dietary influences that affect inflammatory bowel disease (IBD). This Guideline presents the best current evidence.
- There are no known causes for IBD.
- Symptoms include diarrhea, bloating, cramping, gas, fever, bowel bleeding, abdominal pain, weight loss, and anemia.
- This patient summary focuses on dietary components that may be prudent to increase or decrease in patients with inflammatory bowel disease.
Dietary components for inflammatory bowel disease
|Dietary components||Ulcerative colitis||Crohn’s disease|
|Prudent to increase|| || |
|Prudent to reduce/limit|| || |
|Prudent to avoid|| || |
- DHA: Docosahexaenoic Acid
- EPA: Eicosapentaenoic Acid
- IBD: Inflammatory Bowel Disease
Levine, A., Rhodes, J. M., Lindsay, J. O., Abreu, M. T., Kamm, M. A., Gibson, P. R., … Lewis, J. D. (2020). Dietary Guidance for Patients with Inflammatory Bowel Disease from the International Organization for the Study of Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology. doi:10.1016/j.cgh.2020.01.046
The information in this patient summary should not be used as a substitute for professional medical care or advice. Contact a health care provider if you have questions about your health.